TCI Wealth Advisors Inc. Has $259,000 Stock Holdings in Cigna Group (NYSE:CI)

TCI Wealth Advisors Inc. decreased its holdings in Cigna Group (NYSE:CI) by 7.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 787 shares of the health services provider’s stock after selling 67 shares during the quarter. TCI Wealth Advisors Inc.’s holdings in Cigna Group were worth $259,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in CI. TCTC Holdings LLC bought a new stake in shares of Cigna Group in the 4th quarter worth about $25,000. Putney Financial Group LLC bought a new stake in shares of Cigna Group in the 4th quarter worth about $36,000. Transce3nd LLC bought a new stake in shares of Cigna Group in the 4th quarter worth about $38,000. Ameriflex Group Inc. bought a new stake in shares of Cigna Group in the 4th quarter worth about $44,000. Finally, Heck Capital Advisors LLC bought a new stake in shares of Cigna Group in the 4th quarter worth about $53,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Mizuho upped their target price on shares of Cigna Group from $360.00 to $384.00 and gave the stock an “outperform” rating in a report on Wednesday, April 9th. Barclays reaffirmed an “overweight” rating and issued a $385.00 target price (up previously from $382.00) on shares of Cigna Group in a report on Monday, June 2nd. Piper Sandler increased their price objective on shares of Cigna Group from $348.00 to $374.00 and gave the stock an “overweight” rating in a report on Monday, May 5th. Robert W. Baird decreased their price objective on shares of Cigna Group from $388.00 to $362.00 and set an “outperform” rating on the stock in a report on Tuesday, April 15th. Finally, Royal Bank Of Canada reissued an “outperform” rating and set a $371.00 price objective on shares of Cigna Group in a report on Tuesday, June 3rd. Two research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $380.39.

Cigna Group Stock Performance

Cigna Group stock opened at $314.34 on Friday. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.65. Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The company has a market cap of $83.97 billion, a PE ratio of 17.41, a PEG ratio of 0.93 and a beta of 0.44. The company’s 50-day moving average is $321.79 and its two-hundred day moving average is $307.93.

Cigna Group (NYSE:CI) last released its earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.35 by $0.39. Cigna Group had a net margin of 1.97% and a return on equity of 18.63%. The company had revenue of $65.45 billion for the quarter, compared to the consensus estimate of $60.39 billion. During the same period in the prior year, the company posted $6.47 EPS. The company’s revenue was up 14.4% compared to the same quarter last year. Equities analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 18th. Investors of record on Tuesday, June 3rd were given a $1.51 dividend. The ex-dividend date of this dividend was Tuesday, June 3rd. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.92%. Cigna Group’s dividend payout ratio is 33.44%.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.